References
1a
1,3-Dipolar Cycloaddition Chemistry
Padwa A.
Wiley;
New York:
1984.
1b
Pérez P.
Domingo LR.
Aurell MJ.
Contreras R.
Tetrahedron
2003,
59:
3117
2a
Dondas HA.
Grigg R.
Hadjisoteriu M.
Markandu J.
Thomas WA.
Kennewell P.
Tetrahedron
2000,
56:
10087
2b
Dondas HA.
Grigg R.
Hadjisoteriu M.
Markandu J.
Kennewell P.
Thornton-Pett M.
Tetrahedron
2001,
57:
1119
2c
Dunn PJ.
Graham AB.
Grigg R.
Saba IS.
Thornton-Pett M.
Tetrahedron
2002,
58:
7701
3
Frank É.
Wölfling J.
Aukszi B.
König V.
Schneider TR.
Schneider G.
Tetrahedron
2002,
58:
6843
4a
Schönecker B.
Lange C.
Kötteritzsch M.
Günther W.
Weston J.
Anders E.
Görls H.
J. Org. Chem.
2000,
65:
5487
4b
Altona C.
Geise HJ.
Romers C.
Tetrahedron
1968,
24:
13
4c
Mernyák E.
Schönecker B.
Lange C.
Kötteritzsch M.
Görls H.
Wölfling J.
Schneider G.
Steroids
2003,
68:
289
4d
Nambara T.
Kudo T.
Hosoda H.
Titaka Y.
Kikutani N.
Chem. Pharm. Bull.
1975,
23:
320
4e
Nambara T.
Kudo T.
Chem. Pharm. Bull.
1972,
20:
2156
5a
Frank É.
Mernyák E.
Wölfling J.
Schneider G.
Synlett
2002,
1803
5b
Wölfling J.
Frank É.
Mernyák E.
Bunkóczi G.
Cuesta Seijo JA.
Schneider G.
Tetrahedron
2002,
58:
6851
6a
Mernyák E.
Wölfling J.
Bunkóczi G.
Luo L.
Schneider TR.
Schneider G.
Collect. Czech. Chem. Commun.
2003,
68:
1141
6b
Wölfling J.
Mernyák E.
Forgó P.
Schneider G.
Steroids
2003,
68:
451
6c
Schneider G.
Bottka S.
Hackler L.
Wölfling J.
Sohár P.
Liebigs Ann. Chem.
1989,
263
7
General Procedure for the Synthesis of 16-Bromomethyl Cycloadducts (7a, 8a).
Compound 3 or 4 (100 mg, ca. 0.33 mmol) was dissolved in CH2Cl2, and DDH (50 mg, ca. 0.17 mmol) or NBS (60 mg, 0.33 mmol) was added. The mixture was then stirred at r.t. for 0.5 h and the solvent was evaporated off. The crude product was dissolved in benzene (5 mL), NPM (58 mg, ca. 0.33 mmol) was added and the solution was stirred at 50 °C for 2 h. After evaporation of the solvent, purification by column chromatography with tert-butyl-methyl ether (30%)-hexane (70%) as eluent yielded 145 mg (81%) of 7a: mp 132-137 °C; R
f
= 0.33 (CH2Cl2). 1H NMR (CDCl3): δ = 1.38 (s, 3 H, 18-H3), 2.87 (m, 2 H, 6-H2), 3.42 (dd, 1 H, J = 9.9 Hz, J = 8.0 Hz, 16a-H), 3.80 (dd, 1 H, J = 9.9 Hz, J = 2.2 Hz, 16a-H), 3.44 (d, 1 H, J = 8.0 Hz, 17a-H), 3.78 (s, 3 H, 3-OMe), 4.33 (t, 1 H, J = 8.0 Hz, 4′-H), 5.09 (d, 1 H, J = 8.0 Hz, 3′-H), 6.64 (d, 1 H, J = 2.4 Hz, 4-H), 6.73 (dd, 1 H, J = 8.6 Hz, J = 2.4 Hz, 2-H), 7.23-7.26 and 7.46 (overlapping multiplets, 5 H, 1-, 2′′-, 3′′-, 5′′-, 6′′-H), 7.40 (t, 1 H, J = 7.3 Hz, 4′′-H) ppm. 13C NMR (CDCl3): δ = 26.4, 27.4, 27.7, 29.8, 34.3 (C-18), 34.9, 36.4, 36.6, 38.3, 42.0, 45.0, 50.3, 55.2, 55.6, 74.6 (C-17a), 77.3 (C-3′), 111.9 (C-2), 113.4 (C-4), 126.4 and 129.2 (2 × 2 C, C-2′′, -3′′, -5′′, -6′′), 126.7 (C-1), 129.0 (C-4′′), 131.1 and 132.3 (2 ¥ l C, C-1′′ and C-10), 137.6 (C-5), 157.8 (C-3), 170.8 and 173.6 (2 ¥ l C, C-2′ and C-5′) ppm. Compound 8a was purified by chromatography with CH2Cl2 as eluent, yielding 120 mg (67%) of the pure product: mp 155-158 °C; R
f
= 0.25 (CH2Cl2). 1H NMR (CDCl3): δ = 1.22 (s, 3 H, 18-H3), 2.78 (m, 1 H, 4′-H), 2.88 (m, 2 H, 6-H2), 3.52 (dd, 1 H, J = 10.1 Hz, J = 7.3 Hz, 16a-H), 3.74 (m, 1 H, 16a-H), 3.54 (d, 1 H, J = 9.2 Hz, 17a-H), 3.77 (s, 3 H, 3-OMe), 5.20 (d, 1 H, J = 8.0 Hz, 3′-H), 6.64 (d, 1 H, J = 2.2 Hz, 4-H), 6.72 (dd, 1 H, J = 8.6 Hz, J = 2.2 Hz, 2-H), 7.20 (d, 1 H, J = 8.6 Hz, 1-H), 7.29 (d, 2 H, J = 7.8 Hz, 2′′-, 6′′-H), 7.41 (t, 1 H, J = 7.8 Hz, 4′′-H), 7.48 (t, 2 H, J = 7.8 Hz, 3′′-, 5′′-H). 13C NMR (CDCl3): δ = 21.3 (C-18), 25.3, 26.5, 28.2, 29.8, 35.4, 37.2, 37.4, 38.4, 41.1, 43.2, 48.5 (C-4′), 55.2 (3-OCH3), 61.2 (C-16), 77.3 (C-17a), 77.9 (C-3′), 111.7 (C-2), 113.5 (C-4), 126.2 and 128.9 (2 × 1 C, C-1 and C-4′′), 126.3 and 129.2 (2 × 2 C, C-2′′, -3′′, -5′′, -6′′), 131.1 and 131.9 (2 ¥ l C, C-1′′ and C-10), 137.5 (C-5), 157.6 (C-3), 170.9 and 173.2
(2 ¥ l C, C-2′and -5′).